Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
International Journal of Cancer · 15.03.2023 · 152 (6) · 1060-1068
DOI: 10.1002/ijc.34286 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 10.10.2022. Verfasst von Matti Lehtinen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical Faculty, Tampere University, Tampere, Finland. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia, Papillomavirus Vaccines. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
This review is based on the recent EUROGIN scientific session: “Assessing risk of cervical cancer in the post‐vaccination era,” which addressed the demands of cervical intraepithelial neoplasia (CIN)/squamous intraepithelial lesion (SIL) triage now that the prevalence of vaccine‐targeted oncogenic high‐risk (hr) human papillomaviruses (HPVs) is decreasing. Change in the prevalence distribution of oncogenic HPV types that follows national HPV vaccination programs is setting the stage for loss of positive predictive value of conventional but possibly also new triage modalities. Understanding the contribution of the latter, most notably hypermethylation of cellular and viral genes in a new setting where most oncogenic HPV types are no longer present, requires studies on their performance in vaccinated women with CIN/SIL that are associated with nonvaccine HPV types. Lessons learned from this research may highlight the potential of cervical cells for risk prediction of all women's cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Faculty, Tampere University, Tampere, Finland.
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.
- Wolfson Institute of Population Health, Queen Mary University of London, London, UK.
- Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland.
- Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, The Netherlands.
ORCID-Profile: Matti Lehtinen, Ville N Pimenoff, Lisanne Verhoef, Joakim Dillner
Förderung
- Cancer Research UK
Zitieren
APA
Lehtinen, M., Pimenoff, V. N., Nedjai, B., Louvanto, K., Verhoef, L., Heideman, D. A. M., El-Zein, M., Widschwendter, M., & Dillner, J. (2023). Assessing the risk of cervical neoplasia in the post‐HPV vaccination era. International Journal of Cancer, 152(6), 1060-1068. https://doi.org/10.1002/ijc.34286
Vancouver
Lehtinen M, Pimenoff VN, Nedjai B, Louvanto K, Verhoef L, Heideman DAM, et al. Assessing the risk of cervical neoplasia in the post‐HPV vaccination era. International Journal of Cancer. 2023;152(6):1060-1068. doi:10.1002/ijc.34286
BibTeX
@article{Lehtinen2023,
author = {Lehtinen, Matti and Pimenoff, Ville N and Nedjai, Belinda and Louvanto, Karolina and Verhoef, Lisanne and Heideman, Daniëlle A M and El-Zein, Mariam and Widschwendter, Martin and Dillner, Joakim},
title = {Assessing the risk of cervical neoplasia in the post‐HPV vaccination era},
journal = {International Journal of Cancer},
year = {2023},
volume = {152},
number = {6},
pages = {1060--1068},
doi = {10.1002/ijc.34286}
}
EUVIMED